Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Regulatory News (EVG)

  • There is currently no data for EVG

Form 8.5 (EPT/RI)

29 Sep 2011 11:25

RNS Number : 1888P
Bank of America Merrill Lynch
29 September 2011
 



FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose Evolution Group Plc

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and

INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0030221864 Purchase 10,713 GBP 0.84 GBP 0.83

Common - GB0030221864 Sale 4,769 GBP 0.84 GBP 0.83

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0030221864 Swap SHORT 3949 GBP 0.83

Common - GB0030221864 Swap SHORT 2877 GBP 0.83

Common - GB0030221864 Swap SHORT 1595 GBP 0.84

Common - GB0030221864 Swap SHORT 1369 GBP 0.83

Common - GB0030221864 Swap SHORT 530 GBP 0.83

Common - GB0030221864 Swap SHORT 378 GBP 0.83

Common - GB0030221864 Swap SHORT 15 GBP 0.83

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0030221864 Swap LONG 545 GBP 0.84

Common - GB0030221864 Swap LONG 1369 GBP 0.83

Common - GB0030221864 Swap LONG 2855 GBP 0.83

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose INVESTEC PLC

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and

INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB00B17BBQ50 Purchase 15,653 GBP 3.74 GBP 3.69

Common - GB00B17BBQ50 Sale 21,524 GBP 3.75 GBP 3.69

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - Swap SHORT 2179 GBP 3.74

Common - Swap SHORT 35 GBP 3.74

Common - Swap SHORT 62 GBP 3.74

Common - Swap SHORT 125 GBP 3.74

Common - Swap SHORT 176 GBP 3.73

Common - Swap SHORT 1053 GBP 3.74

Common - Swap SHORT 1086 GBP 3.71

Common - Swap SHORT 1206 GBP 3.71

Common - Swap SHORT 10 GBP 3.74 

Common - Swap SHORT 10 GBP 3.74

Common - Swap SHORT 1836 GBP 3.70

Common - Swap SHORT 2648 GBP 3.73

Common - Swap SHORT 3540 GBP 3.74

Common - Swap SHORT 1409 GBP 3.74

 

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - Swap LONG 35 GBP 3.75

Common - Swap LONG 8720 GBP 3.72

Common - Swap LONG 3657 GBP 3.70

Common - Swap LONG 2292 GBP 3.70

Common - Swap LONG 1047 GBP 3.72

Common - Swap LONG 661 GBP 3.74

Common - Swap LONG 62 GBP 3.75

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

 

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Balenkosi Dungeni

Telephone number: +44 20 7996 1639

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose Hansen Transmissions International NV

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to Hansen Transmissions

International NV

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - BE0947727377 Purchase 196,658 GBP 0.65 GBP 0.65

Common - BE0947727377 Sale 177,759 GBP 0.65 GBP 0.65

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - BE0947727377 Swap SHORT 12881 GBP 0.65

Common - BE0947727377 Swap SHORT 11225 GBP 0.65

Common - BE0947727377 Swap SHORT 7477 GBP 0.65

Common - BE0947727377 Swap SHORT 6666 GBP 0.65

Common - BE0947727377 Swap SHORT 1034 GBP 0.65

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

 

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose Autonomy Corporation Plc

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to Autonomy Corporation Plc

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0055007982 Purchase 7,972 GBP 25.39 GBP 25.35

Common - GB0055007982 Sale 6,483 GBP 25.38 GBP 25.33

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0055007982 Swap SHORT 3119 GBP 25.38

Common - GB0055007982 Swap SHORT 800 GBP 25.38

Common - GB0055007982 Swap SHORT 132 GBP 25.35

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0055007982 Swap LONG 1 GBP 25.37

Common - GB0055007982 Swap LONG 2 GBP 25.37 

Common - GB0055007982 Swap LONG 2 GBP 25.37

Common - GB0055007982 Swap LONG 2 GBP 25.37

Common - GB0055007982 Swap LONG 3 GBP 25.37

Common - GB0055007982 Swap LONG 5 GBP 25.37

Common - GB0055007982 Swap LONG 20 GBP 25.37

Common - GB0055007982 Swap LONG 27 GBP 25.37

Common - GB0055007982 Swap LONG 103 GBP 25.37

Common - GB0055007982 Swap LONG 715 GBP 25.38

Common - GB0055007982 Swap LONG 800 GBP 25.33

Common - GB0055007982 Swap LONG 819 GBP 25.39

Common - GB0055007982 Swap LONG 2354 GBP 25.33

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBKLFLFKFLBBF
Date   Source Headline
13th Dec 20177:00 amRNSCollaboration with King's College London
11th Dec 20177:15 amRNSHardman Res.: Funded to the end of Phase II trials
8th Dec 20177:15 amRNSPlacing and Notice of General Meeting
8th Dec 20177:00 amRNSInterim Results
23rd Nov 201711:05 amRNSSecond Price Monitoring Extn
23rd Nov 201711:00 amRNSPrice Monitoring Extension
4th Oct 20177:00 amRNSFirst European Patent Grant
31st Aug 20177:00 amRNSIssue of Equity and Total Voting Rights
2nd Aug 20171:00 pmRNSSFX-01 data published in Peer Reviewed Journal
27th Jul 20177:00 amRNSResult of AGM
26th Jul 20177:00 amRNSAGM Statement
11th Jul 201712:30 pmRNSCharity-funded Study of SFX-01 in TNBC
21st Jun 201710:00 amRNSPosting of Annual Report and AGM Notice
21st Jun 20177:15 amRNSHardman Research: Making clinical progress
13th Jun 20177:00 amRNSFull Year Results
1st Jun 20177:00 amRNSCompassionate Use Programme and Trials Update
25th May 20177:00 amRNSNotice of Preliminary Results
3rd Apr 20172:15 pmRNSDirectorate Change
28th Mar 20172:45 pmRNSFurther US Patent Grant
6th Mar 20177:00 amRNSIssue of Equity, PDMR Shareholding and TVR
14th Feb 20171:30 pmRNSPatent Grant in the United States
13th Feb 20177:00 amRNSServices Agreement with APTrans
17th Jan 20177:00 amRNSFirst Patient Dosed in Breast Cancer Trial
17th Jan 20177:00 amRNSAppointment of CFO and Head of Clinical Operations
11th Jan 20177:00 amRNSPositive DSMB Review of SAS Trial
5th Dec 20167:00 amRNSHalf Yearly Report
29th Nov 201611:53 amRNSHardman Research: Clinical sulforaphane potential
17th Nov 20167:00 amRNSNotice of Interim Results
1st Nov 201612:30 pmRNSGrant of Options
15th Sep 20167:00 amRNSUpdate re SFX-01 Data at ECTRIMS 2016
8th Sep 20163:30 pmRNSPresentation of SFX-01 Data at ECTRIMS 2016
24th Aug 20163:15 pmRNSOrphan Designation in the USA in SAH
17th Aug 20167:00 amRNSApproval for Phase II Study in Breast Cancer
24th Jun 20163:36 pmRNSResult of AGM
9th Jun 20167:00 amRNSGrant of Options
2nd Jun 20167:00 amRNSPosting of Annual Report and AGM Notice
31st May 20167:00 amRNSFinal Results
9th May 20167:00 amRNSNotification of Preliminary Results
3rd May 20167:00 amRNSFirst Patient Dosed in Phase II Trial
2nd Mar 20167:00 amRNSApproval of Phase II Clinical Trial in SAH
19th Jan 20163:23 pmRNSCorrection: Director Share Purchases
19th Jan 20167:00 amRNSDirector Share Purchases
11th Jan 20167:00 amRNSExercise of Options
4th Jan 20167:00 amRNSAppoints Chief Medical Officer
7th Dec 20157:00 amRNSHalf Yearly Report
23rd Nov 20157:00 amRNSExpands Pipeline with Novel Compounds
16th Nov 20157:00 amRNSNotification of Half Year Results
23rd Oct 201511:45 amRNSNotification of Major Interest in Shares
21st Oct 20157:00 amRNSFirst Day of Dealings
21st Dec 20114:30 pmRNSTemporary Suspension Evolution Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.